| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52687-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35292-10ug | |||
| Carrier-Free | NBP2-35292-1mg | |||
| Carrier-Free | NBP2-35292-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34868-10ug | |||
| Carrier-Free | NBP2-34868-1mg | |||
| Carrier-Free | NBP2-34868-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35896-500ug | |||
| Carrier-Free | NBP2-35896-1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35153-1mg | |||
| Carrier-Free | NBP2-35153-100ug | |||
| Carrier-Free | NBP2-35153-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81111-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35171-1mg | |||
| Carrier-Free | NBP2-35171-100ug | |||
| Carrier-Free | NBP2-35171-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50606-0.025ml | |||
![Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) - Chimeric [NBP2-52687] - Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of R4930 (NBP2-52687, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/OX40-Ligand-TNFSF4-Antibody-R4930-Oxelumab-Chimeric-Flow-Cytometry-NBP2-52687-img0001.jpg "Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) - Chimeric [NBP2-52687] - Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of R4930 (NBP2-52687, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Rat Cardiotrophin-1/CT-1 Protein [NBP2-35292]](http://images.novusbio.com/fullsize/Rat-Cardiotrophin-1-CT-1-Protein-SDS-Page-NBP2-35292-img0001.jpg "SDS-Page: Rat Cardiotrophin-1/CT-1 Protein [NBP2-35292]")
![SDS-Page: Recombinant Human IGF-I/IGF-1 LR3 Protein [NBP2-61314]](http://images.novusbio.com/fullsize/nbp2-61314_recombinant-human-igf-i-igf-1-lr3-protein-512024857291.png "SDS-Page: Recombinant Human IGF-I/IGF-1 LR3 Protein [NBP2-61314]")
![SDS-Page: Human Flt-3 Ligand Protein [NBP2-34868]](http://images.novusbio.com/fullsize/Human-Flt-3-Ligand-Protein-SDS-Page-NBP2-34868-img0001.jpg "SDS-Page: Human Flt-3 Ligand Protein [NBP2-34868]")
![SDS-Page: Human IGF-I 15N Protein [NBP2-35896]](http://images.novusbio.com/fullsize/Human-IGF-I-15N-Protein-SDS-Page-NBP2-35896-img0001.jpg "SDS-Page: Human IGF-I 15N Protein [NBP2-35896]")
![SDS-Page: Mouse LIF Protein [NBP2-35153]](http://images.novusbio.com/fullsize/Mouse-LIF-Protein-SDS-Page-NBP2-35153-img0001.jpg "SDS-Page: Mouse LIF Protein [NBP2-35153]")
![Flow Cytometry: Fibrin beta-chain Antibody (8E5) - Chimeric [NBP2-81111] - Flow-cytometry using the Fibrin beta-chain Antibody [NBP2-81111]. HepG2 cells were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with anti-Fluorescein IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of 8E5 (NBP2-81111, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Fibrinopeptide-B-Antibody-8E5-Chimeric-Flow-Cytometry-NBP2-81111-img0001.jpg "Flow Cytometry: Fibrin beta-chain Antibody (8E5) - Chimeric [NBP2-81111] - Flow-cytometry using the Fibrin beta-chain Antibody [NBP2-81111]. HepG2 cells were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with anti-Fluorescein IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of 8E5 (NBP2-81111, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Mouse Midkine Protein [NBP2-35171]](http://images.novusbio.com/fullsize/Mouse-Midkine-Protein-SDS-Page-NBP2-35171-img0001.jpg "SDS-Page: Mouse Midkine Protein [NBP2-35171]")
![Immunocytochemistry /Immunofluorescence: Fibrin beta-chain Antibody (59D8) - Chimeric - BSA Free [NBP3-43555] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on Shi-fix coverslips stained with NBP3-43555 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43555, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-43555_rabbit-fibrin-beta-chain-mab-59d8-chimeric-azide-bsa-free-7420252214120.png "Immunocytochemistry /Immunofluorescence: Fibrin beta-chain Antibody (59D8) - Chimeric - BSA Free [NBP3-43555] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on Shi-fix coverslips stained with NBP3-43555 (1:100 dilution) for 1h followed by Alexa Fluor 488 secondary antibody (1:1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43555, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor 488 secondary antibody.")
![Western Blot: Fibrin beta-chain Antibody (59D8) - Chimeric - BSA Free [NBP3-43555] - Human liver (A), placenta (B), and serum (C) tissue lysates (35ug protein in RIPA buffer) were resolved via SDS-PAGE, and the subsequent blots were probed with NBP3-43555 at 0.01ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-43555_rabbit-fibrin-beta-chain-mab-59d8-chimeric-azide-bsa-free-74202522113014.png)
![Western Blot: Fibrin beta-chain Antibody (59D8) - BSA Free [NBP3-43554] - Human liver (A), placenta (B), and serum (C) tissue lysates (35µg protein in RIPA buffer) were resolved via SDS-PAGE, and the subsequent blots were probed with NBP3-43554 at 0.01µg/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.](http://images.novusbio.com/fullsize/nbp3-43554_mouse-fibrin-beta-chain-mab-59d8-azide-and-bsa-free-western-blot-2220260351115.png "Western Blot: Fibrin beta-chain Antibody (59D8) - BSA Free [NBP3-43554] - Human liver (A), placenta (B), and serum (C) tissue lysates (35µg protein in RIPA buffer) were resolved via SDS-PAGE, and the subsequent blots were probed with NBP3-43554 at 0.01µg/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1 hour was used, and proteins were detected by chemiluminescence.")
![Immunocytochemistry/ Immunofluorescence: Fibrin beta-chain Antibody (59D8) - BSA Free [NBP3-43554] - Immunofluorescence analysis of paraformaldehyde fixed HepG2 cells on coverslips stained with NBP3-43554 (1:100 dilution) for 1h followed by Alexa Fluor® 488 secondary antibody (1:1000 dilution), showing cytoplasmic staining. The nuclear stain is DAPI (blue). Panels show, from left-right, top-bottom, NBP3-43554, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor® 488 secondary antibody.](http://images.novusbio.com/fullsize/nbp3-48432_rabbit-vaccinia-virus-b18r-pab-azide-and-bsa-free-western-blot-2220260311813.png)
![Western Blot: AIF Antibody (3C11) [NBP2-50606] - Western blot was performed on transfected 293T cell lysates using anti-AIF [3C11].](http://images.novusbio.com/fullsize/AIF-Antibody-3C11-Western-Blot-NBP2-50606-img0001.jpg "Western Blot: AIF Antibody (3C11) [NBP2-50606] - Western blot was performed on transfected 293T cell lysates using anti-AIF [3C11].")
![Western Blot: AIF [p Ser116] Antibody [NBP3-23346] - Western blot image of human jurkat cells untreated (lanes 1 & 3) or treated with calyculin A (100 nM, 30 min.) (lanes 2 and 4). The blot was probed with rabbit polyclonals anti-AIF (C-terminal region) at 1:500 (lanes 1 & 2) and anti-AIF (Ser-116) phospho-specific antibody at 1:1000 (lanes 3 & 4).](http://images.novusbio.com/fullsize/nbp3-23346_rabbit-aif-p-ser116-pab-1992023191546.jpg "Western Blot: AIF [p Ser116] Antibody [NBP3-23346] - Western blot image of human jurkat cells untreated (lanes 1 & 3) or treated with calyculin A (100 nM, 30 min.) (lanes 2 and 4). The blot was probed with rabbit polyclonals anti-AIF (C-terminal region) at 1:500 (lanes 1 & 2) and anti-AIF (Ser-116) phospho-specific antibody at 1:1000 (lanes 3 & 4).")